327.36
price up icon0.77%   2.50
after-market 시간 외 거래: 330.00 2.64 +0.81%
loading
전일 마감가:
$324.86
열려 있는:
$324.13
하루 거래량:
3.84M
Relative Volume:
1.23
시가총액:
$175.61B
수익:
$33.42B
순이익/손실:
$4.09B
주가수익비율:
43.36
EPS:
7.55
순현금흐름:
$10.39B
1주 성능:
+5.33%
1개월 성능:
+11.05%
6개월 성능:
-0.48%
1년 성능:
+19.58%
1일 변동 폭
Value
$322.77
$335.88
1주일 범위
Value
$310.14
$335.88
52주 변동 폭
Value
$253.30
$346.85

암젠 Stock (AMGN) Company Profile

Name
명칭
Amgen Inc
Name
전화
(805)447-1000
Name
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
직원
26,700
Name
트위터
@amgen
Name
다음 수익 날짜
2025-02-04
Name
최신 SEC 제출 서류
Name
AMGN's Discussions on Twitter

AMGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
AMGN
Amgen Inc
327.36 175.61B 33.42B 4.09B 10.39B 7.55
Drug Manufacturers - General icon
LLY
Lilly Eli Co
829.76 788.61B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
216.66 382.48B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
78.95 350.46B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
JNJ
Johnson Johnson
167.70 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
MRK
Merck Co Inc
95.23 251.88B 64.17B 17.12B 18.10B 6.73

암젠 Stock (AMGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-10 재개 BofA Securities Underperform
2024-11-15 개시 Wolfe Research Peer Perform
2024-11-14 개시 Citigroup Neutral
2024-10-17 개시 Bernstein Outperform
2024-10-14 다운그레이드 Truist Buy → Hold
2024-09-27 개시 Cantor Fitzgerald Overweight
2024-08-07 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-05-03 업그레이드 Barclays Underweight → Equal Weight
2024-05-03 업그레이드 William Blair Mkt Perform → Outperform
2024-03-28 재개 Raymond James Mkt Perform
2024-02-07 다운그레이드 Leerink Partners Outperform → Market Perform
2023-12-21 업그레이드 Daiwa Securities Neutral → Buy
2023-12-19 업그레이드 BMO Capital Markets Market Perform → Outperform
2023-12-12 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-11-09 개시 Deutsche Bank Hold
2023-11-02 업그레이드 Truist Hold → Buy
2023-10-20 재개 JP Morgan Neutral
2023-10-17 재개 Morgan Stanley Equal-Weight
2023-10-11 재개 BofA Securities Neutral
2023-09-06 개시 HSBC Securities Buy
2023-04-24 재확인 Oppenheimer Outperform
2023-03-13 업그레이드 Wells Fargo Equal Weight → Overweight
2023-02-13 재확인 Truist Buy
2022-11-18 개시 Credit Suisse Underperform
2022-10-31 다운그레이드 Barclays Equal Weight → Underweight
2022-10-11 업그레이드 Morgan Stanley Equal-Weight → Overweight
2022-05-23 개시 SVB Leerink Mkt Perform
2022-02-09 재확인 Barclays Equal Weight
2022-02-09 재확인 Jefferies Buy
2022-02-09 재확인 Morgan Stanley Equal-Weight
2022-02-09 재확인 Oppenheimer Outperform
2022-02-09 재확인 Wells Fargo Equal Weight
2022-01-05 다운그레이드 BofA Securities Buy → Neutral
2021-12-09 재개 Wells Fargo Equal Weight
2021-12-06 개시 Goldman Buy
2021-11-19 개시 BMO Capital Markets Market Perform
2021-09-23 다운그레이드 Daiwa Securities Outperform → Neutral
2021-09-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-12-29 개시 Daiwa Securities Buy
2020-10-28 개시 UBS Neutral
2020-10-26 업그레이드 Raymond James Mkt Perform → Outperform
2020-10-12 업그레이드 Truist Hold → Buy
2020-10-09 다운그레이드 Bernstein Outperform → Mkt Perform
2020-10-09 다운그레이드 Truist Buy → Hold
2020-10-08 다운그레이드 Raymond James Outperform → Mkt Perform
2020-04-15 재개 Guggenheim Neutral
2020-03-31 개시 Wolfe Research Peer Perform
2020-03-30 업그레이드 Raymond James Mkt Perform → Outperform
2020-03-05 업그레이드 BofA/Merrill Neutral → Buy
2020-02-27 개시 Barclays Equal Weight
2020-01-31 다운그레이드 Robert W. Baird Neutral → Underperform
2020-01-21 업그레이드 Evercore ISI In-line → Outperform
2019-12-24 개시 Raymond James Mkt Perform
2019-12-17 재개 Morgan Stanley Overweight
2019-11-12 개시 SunTrust Buy
2019-11-05 업그레이드 Cantor Fitzgerald Neutral → Overweight
2019-10-17 재개 BofA/Merrill Neutral
2019-08-19 다운그레이드 Mizuho Buy → Neutral
2019-05-23 업그레이드 Citigroup Neutral → Buy
모두보기

암젠 주식(AMGN)의 최신 뉴스

pulisher
Mar 10, 2025

Candriam S.C.A. Cuts Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen, Fresenius Settle Osteoporosis Drug Patent Dispute - Law360

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen: Riding The MariTide Of Monthly Weight Loss (NASDAQ:AMGN) - Seeking Alpha

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen : Update on Patent Litigation Related to Fresenius Denosumab Biosimilar Products - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen continues gains for seven straight sessions (AMGN:NASDAQ) - Seeking Alpha

Mar 10, 2025
pulisher
Mar 10, 2025

Callan Family Office LLC Acquires 11,801 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen, Fresenius Settle Suit Over Prolia, Xgeva Biosimilars (1) - Bloomberg Law

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen And Kyowa Kirin's Rocatinlimab Reduces Eczema Severity In Phase 3 Study - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

Protein Engineering Market Projected To Witness Substantial Growth, 2025-2032: Agilent Technologies Inc., - EIN News

Mar 10, 2025
pulisher
Mar 10, 2025

AMGN's Eczema Drug Meets Goal in Two Late-Stage Studies - Zacks Investment Research

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen’s rocatinlimab picks up steam with late-stage atopic dermatitis win - PharmaLive

Mar 10, 2025
pulisher
Mar 10, 2025

Argentarii LLC Makes New $357,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Sound View Wealth Advisors Group LLC Purchases 1,159 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Ellerson Group Inc. ADV Has $3.17 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Samsung, Celltrion lead biosimilar market in Europe, US - Korea Economic Daily

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen, Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Daiwa Securities Group Inc. Has $54.26 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

2,128 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Vista Investment Partners II LLC - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen and Kyowa Kirin announce rocatinlimab Phase III success - The Pharma Letter

Mar 10, 2025
pulisher
Mar 10, 2025

Meriwether Wealth & Planning LLC Makes New $417,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Take the Zacks Approach to Beat the Markets: NioCorp, AngloGold, Amgen in Focus - Zacks Investment Research

Mar 10, 2025
pulisher
Mar 10, 2025

Zurcher Kantonalbank Zurich Cantonalbank Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Sowell Financial Services LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

OFI Invest Asset Management Buys New Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Bank Julius Baer & Co. Ltd Zurich Sells 5,274 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Banco Santander S.A. - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Cancer Biologics Market Projected To Witness Substantial Growth 2025-2032:Amgen Inc., Pfizer Inc., Sanofi S.A, - EIN News

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Verdence Capital Advisors LLC - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

E Fund Management Co. Ltd. Increases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

What is William Blair’s Forecast for Amgen Q4 Earnings? - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Amgen (NASDAQ:AMGN) Given New $294.00 Price Target at Bank of America - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Townsend Asset Management Corp NC ADV Purchases 2,166 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

What is William Blair's Forecast for Amgen Q4 Earnings? - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

Beacon Harbor Wealth Advisors Inc. Buys Shares of 13,548 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 10, 2025
pulisher
Mar 09, 2025

Ethos Financial Group LLC Acquires 923 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Raymond James Financial Inc. Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Cullen Frost Bankers Inc. Has $23.93 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Atria Investments Inc Sells 2,435 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Arizona State Retirement System Has $40.55 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Amgen, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

HM Payson & Co. Increases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Rialto Wealth Management LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Kendall Capital Management Trims Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Amundi Has $687.47 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Intellectus Partners LLC Buys New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Machina Capital S.A.S. Lowers Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Andra AP fonden Purchases 12,400 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

1 Dividend Stock Down 30% to Buy and Hold for the Next Decade - The Motley Fool

Mar 09, 2025
pulisher
Mar 09, 2025

Generali Investments CEE investicni spolecnost a.s. Purchases Shares of 14,720 Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

PNC Financial Services Group Inc. Sells 21,757 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

Mar 09, 2025
pulisher
Mar 09, 2025

Q1 Earnings Forecast for Amgen Issued By William Blair - Defense World

Mar 09, 2025

암젠 (AMGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general PFE
$26.64
price down icon 0.34%
drug_manufacturers_general SNY
$59.35
price up icon 0.17%
$117.21
price down icon 0.17%
drug_manufacturers_general NVS
$115.47
price down icon 0.09%
drug_manufacturers_general MRK
$95.23
price up icon 0.61%
자본화:     |  볼륨(24시간):